News

Filter

201 to 210 of 96179 results

Exelixis says cabozantinib failed in Ph III prostate cancer trial

Exelixis says cabozantinib failed in Ph III prostate cancer trial

02-09-2014

US biotech firm Exelixis has posted disappointing top-line results from the final analysis of COMET-1,…

BiotechnologycabozantinibExelixisOncologyResearchSwedish Orphan Biovitrum

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

02-09-2014

German pharma and chemical major Bayer has released results from the X-VeRT* study, demonstrating that…

BayerCardio-vascularPharmaceuticalResearchXarelto

bluebird bio poised to advance gene therapy pipeline

bluebird bio poised to advance gene therapy pipeline

02-09-2014

US clinical-stage biotech firm bluebird bio is advancing a pipeline focused on gene therapy, a rapidly…

Biotechnologybluebird bioCelgene Corp.OncologyRare diseasesResearch

Novo Nordisk pulls out of inflammatory disorders research

Novo Nordisk pulls out of inflammatory disorders research

02-09-2014

Danish diabetes care giant Novo Nordisk says it has decided to discontinue all its R&D activities within…

Anti-Arthritics/RheumaticsInflammatory diseasesNovo NordiskPharmaceutical

Ipsen receives priority review for sNDA for Somatuline

Ipsen receives priority review for sNDA for Somatuline

01-09-2014

French drugmaker Ipsen has received priority review for its supplemental New Drug Application from the…

Gastroenteropancreatic neuroendocrine tumorsIpsenOncologyPharmaceuticalRegulationSomatulineUS Food and Drug AdministrationUSA

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

01-09-2014

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo…

AdvairCiplaGenericsIndiaMarkets & MarketingRespiratory and Pulmonary

New EMA guidance on EU periodic-safety-update-report single assessment for nationally authorized medicines

01-09-2014

The European Medicines Agency has updated its procedural guidance to ensure that marketing-authorization…

EuropePharmaceuticalRegulation

201 to 210 of 96179 results

Back to top